RE:RE:BS - why Phase 3 Bucillamine not included !
I forgot to post this here:
Buy out? Do people even read!?
Commercialization Rights!
MF said it. "The Company is in discussions with reputable international pharmaceutical companies seeking to obtain commercial rights to Bucillamine as a treatment for COVID-19 in various countries in Europe, India and Asia"
I don't know what the deals' $ or % numbers will be but I would expect a similar format to this:
US$20 million on signing. 50 percent on the first US$200 million in annual net sales, then 40 percent on the next US$200 million, then 35 percent on net sales greater than US$400 million. This would be about $250mill per year per deal. Add a few deals and we'd be a multi-billion $ company in no time. Let's say 4 hemispheres. That's a Billion Cash a year! Plus deals can include further R and D costs.
That is just the format. Not the exact numbers to expect.